These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 1850003
1. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus. Sung NS, Kenney S, Gutsch D, Pagano JS. J Virol; 1991 May; 65(5):2164-9. PubMed ID: 1850003 [Abstract] [Full Text] [Related]
2. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Lupton S, Levine AJ. Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506 [Abstract] [Full Text] [Related]
3. Host cell and EBNA-2 regulation of Epstein-Barr virus latent-cycle promoter activity in B lymphocytes. Rooney CM, Brimmell M, Buschle M, Allan G, Farrell PJ, Kolman JL. J Virol; 1992 Jan; 66(1):496-504. PubMed ID: 1309259 [Abstract] [Full Text] [Related]
4. Methylation of discrete sites within the enhancer region regulates the activity of the Epstein-Barr virus BamHI W promoter in Burkitt lymphoma lines. Jansson A, Masucci M, Rymo L. J Virol; 1992 Jan; 66(1):62-9. PubMed ID: 1370095 [Abstract] [Full Text] [Related]
5. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. Wang F, Kikutani H, Tsang SF, Kishimoto T, Kieff E. J Virol; 1991 Aug; 65(8):4101-6. PubMed ID: 1649318 [Abstract] [Full Text] [Related]
6. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral BamHI C promoter. Jin XW, Speck SH. J Virol; 1992 May; 66(5):2846-52. PubMed ID: 1313905 [Abstract] [Full Text] [Related]
7. Identification of a novel promoter located within the Bam HI Q region of the Epstein-Barr virus genome for the EBNA 1 gene. Tsai CN, Liu ST, Chang YS. DNA Cell Biol; 1995 Sep; 14(9):767-76. PubMed ID: 7669254 [Abstract] [Full Text] [Related]
8. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. Tsang SF, Wang F, Izumi KM, Kieff E. J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373 [Abstract] [Full Text] [Related]
9. trans activation of an Epstein-Barr viral transcriptional enhancer by the Epstein-Barr viral nuclear antigen 1. Reisman D, Sugden B. Mol Cell Biol; 1986 Nov; 6(11):3838-46. PubMed ID: 3025615 [Abstract] [Full Text] [Related]
10. oriP is essential for EBNA gene promoter activity in Epstein-Barr virus-immortalized lymphoblastoid cell lines. Puglielli MT, Woisetschlaeger M, Speck SH. J Virol; 1996 Sep; 70(9):5758-68. PubMed ID: 8709191 [Abstract] [Full Text] [Related]
11. The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines. Schaefer BC, Strominger JL, Speck SH. J Virol; 1995 Aug; 69(8):5039-47. PubMed ID: 7609074 [Abstract] [Full Text] [Related]
12. Transcription start sites downstream of the Epstein-Barr virus (EBV) Fp promoter in early-passage Burkitt lymphoma cells define a fourth promoter for expression of the EBV EBNA-1 protein. Nonkwelo C, Skinner J, Bell A, Rickinson A, Sample J. J Virol; 1996 Jan; 70(1):623-7. PubMed ID: 8523583 [Abstract] [Full Text] [Related]
13. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif. Ling PD, Ryon JJ, Hayward SD. J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484 [Abstract] [Full Text] [Related]
14. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1. Ling PD, Hsieh JJ, Ruf IK, Rawlins DR, Hayward SD. J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421 [Abstract] [Full Text] [Related]
15. Reciprocal regulation of the Epstein-Barr virus BamHI-F promoter by EBNA-1 and an E2F transcription factor. Sung NS, Wilson J, Davenport M, Sista ND, Pagano JS. Mol Cell Biol; 1994 Nov; 14(11):7144-52. PubMed ID: 7935429 [Abstract] [Full Text] [Related]
16. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA. Dillner J, Kallin B, Ehlin-Henriksson B, Timar L, Klein G. Int J Cancer; 1985 Mar 15; 35(3):359-66. PubMed ID: 2982749 [Abstract] [Full Text] [Related]
17. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. Schaefer BC, Woisetschlaeger M, Strominger JL, Speck SH. Proc Natl Acad Sci U S A; 1991 Aug 01; 88(15):6550-4. PubMed ID: 1713681 [Abstract] [Full Text] [Related]
18. Transcription of the Epstein-Barr virus gene EBNA-1 from different promoters in nasopharyngeal carcinoma and B-lymphoblastoid cells. Smith PR, Griffin BE. J Virol; 1992 Feb 01; 66(2):706-14. PubMed ID: 1370554 [Abstract] [Full Text] [Related]
19. Dual EBNA1 promoter usage by Epstein-Barr virus in human B-cell lines expressing unique intermediate cellular phenotypes. Taylor KA, Wetzel S, Lyles DS, Pollok BA. J Virol; 1994 Oct 01; 68(10):6421-31. PubMed ID: 8083980 [Abstract] [Full Text] [Related]
20. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa. Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E. J Virol; 1995 May 01; 69(5):3108-16. PubMed ID: 7707539 [Abstract] [Full Text] [Related] Page: [Next] [New Search]